Company receives second Innovate UK Smart Grant Collaboration with King’s College London London, 21 October 2020 – Epsilogen Ltd, a global leader in the development of novel immunoglobulin E (IgE) antibodies to treat cancer, today announced the...
October 21, 2020 - Press Releases